Zyban® (bupropion hydrochloride) 150mg prolonged release tablets will be out of stock from week commencing 15th June 2020 until the end of November 2020.
Unlicensed supplies of bupropion 150mg prolonged release tablets have been sourced.
Champix® (varenicline tartrate) tablets, which are licensed for the treatment of nicotine dependence, are available.
Various nicotine replacement therapies (NRT) are also available.
This alert contains advice on the management of affected patients.